Vanguard Asset Management
DNA icon

Vanguard Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Vanguard Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$309K Hold
24,059
– – ﹤0.01% 2331
2026
Q2 		$238K Hold
24,059
– – ﹤0.01% 2363
2026
Q1 		$147K Buy
+24,059
New +$200K ﹤0.01% 2398

Other funds holding DNA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Vanguard Asset Management's DNA Position: Q3 2026 in Review

Vanguard Asset Management held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 24,059 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #2331.

Vanguard Asset Management first reported a position in DNA in Q1 2026 and has held it in 3 quarters since. 128 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Vanguard Asset Management held 24,059 shares of Ginkgo Bioworks worth $309K as of Q3 2026.
  • Vanguard Asset Management left its Ginkgo Bioworks share count unchanged in Q3 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2331 holding.
  • Vanguard Asset Management first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 3 quarters since.
  • 128 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.